Journal Home
Search for

Volume 70, Issue 5, Pages 881-887 (November 2009)


View previous. 18 of 56 View next.

Continuing Medical EducationAuthor interview seriesEndoscopic cyanoacrylate versus transjugular intrahepatic portosystemic shunt for gastric variceal bleeding: a single-center U.S. analysis

Nicholas J. Procaccini, MD, JD, MSCorresponding Author Information, Abdullah M.S. Al-Osaimi, MD, Patrick Northup, MD, MS, Curtis Argo, MD, MS, Stephen H. Caldwell, MD

Received 30 September 2008; accepted 20 March 2009. published online 26 June 2009.

Refers to article:
CME Activity: Continuing Medical Education Exam: November 2009
Raquel E. Davila, Jeffrey H. Lee, William Ross, Shou-Jiang Tang, G.S. Raju, George Triadafilopoulos
Gastrointestinal Endoscopy
November 2009 (Vol. 70, Issue 5, Pages 976-976.e6)
Full-Text PDF (4806 KB)
Background and Objectives

Gastric variceal hemorrhage treatment remains a difficult issue for clinicians. There is controversy regarding whether first-line treatment should be endoscopic therapy with cyanoacrylate glue or placement of a transjugular intrahepatic portosystemic shunt (TIPS). We compared these methods on the basis of rebleeding, survival, and complications.

Design, Setting, Patients, and Interventions

This was a retrospective cohort analysis of cirrhotic patients with gastric variceal hemorrhage treated with endoscopic cyanoacrylate therapy or TIPS placement at a single U.S. center from 1997 to 2007. The groups were compared for rebleeding at 72 hours, 3 months, and 1 year; survival rates at 3 months and 1 year; and acute and extended complications and morbidity.

Main Outcome Measurements and Results

A total of 105 patients were included. There were no significant pretreatment differences between the 2 groups in age, sex, MELD (Model for End-Stage Liver Disease) score at the time of admission, or cause of liver disease. There were no significant differences in rebleeding at 72 hours, 3 months, and 1 year; survival at 3 months and 1 year; and aggregate long-term survival or acute complications. However, the TIPS group had a higher rate of long-term morbidity requiring hospitalization (41% with a TIPS and 1.6% in the cyanoacrylate arm, P < .0001).

Limitations

Retrospective and uncontrolled samples.

Conclusion

In patients with similar characteristics, cyanoacrylate therapy performed as well as a TIPS in controlling and preventing gastric variceal hemorrhage with no significant differences in survival. Patients receiving cyanoacrylate therapy experienced significantly less long-term morbidity related to therapy than patients who received a TIPS. Cyanoacrylate therapy appears to be safe and effective and compares favorably with TIPS therapy.

Charlottesville, Virginia, USA

Current affiliations: Division of Gastroenterology and Hepatology, Digestive Health Center of Excellence. University of Virginia Health System, Charlottesville, Virginia, USA

Corresponding Author InformationReprint requests: Nicholas Procaccini, MD, Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Virginia Health System, PO Box 800708, Charlottesville, VA 22908-0708.

 DISCLOSURE: All authors disclosed no financial relationship relevant to this publication.

 See CME section; p. 976.

PII: S0016-5107(09)01702-7

doi:10.1016/j.gie.2009.03.1169


View previous. 18 of 56 View next.